;UMLS_CUI;n_gen;disnet_id;n_sympton;OrphaCode;Orphanet_name;UMLS_name;ICD_category_name;disnet_name
34;C0018852;2;DIS007632;65;86864;Heavy chain disease;Heavy Chain Disease;Neoplasms;Heavy chain disease
52;C0022739;8;DIS004874;32;90308;Klippel-Trénaunay syndrome;Klippel-Trenaunay-Weber Syndrome;Congenital malformations, deformations and chromosomal abnormalities;Klippel–Trénaunay syndrome
54;C0022739;8;DIS009437;12;90308;Klippel-Trénaunay syndrome;Klippel-Trenaunay-Weber Syndrome;Congenital malformations, deformations and chromosomal abnormalities;Klippel-Trenaunay syndrome
56;C0023437;2;DIS005568;1;86849;Acute basophilic leukemia;Acute Basophilic Leukemia;Neoplasms;Acute basophilic leukemia
59;C0023481;7;DIS006602;6;86829;Chronic neutrophilic leukemia;Chronic Neutrophilic Leukemia;Neoplasms;Chronic neutrophilic leukemia
113;C0034494;13;DIS006827;48;770;Rabies;Rabies (disorder);Certain infectious and parasitic diseases;Rabies
123;C0040896;1;DIS005886;37;863;Trichinellosis;Trichinellosis;Certain infectious and parasitic diseases;Trichinosis
135;C0043395;2;DIS003893;50;99829;Yellow fever;Yellow Fever;Certain infectious and parasitic diseases;Yellow fever
138;C0079293;1;DIS005896;25;46487;Epidermolysis bullosa acquisita;Epidermolysis Bullosa Acquisita;Diseases of the skin and subcutaneous tissue;Epidermolysis bullosa acquisita
177;C0152267;12;DIS003466;87;98846;Classic Hodgkin lymphoma, lymphocyte-depleted type;Hodgkin lymphoma, lymphocyte depletion;Neoplasms;Hodgkin's lymphoma
178;C0152267;12;DIS013438;111;98846;Classic Hodgkin lymphoma, lymphocyte-depleted type;Hodgkin lymphoma, lymphocyte depletion;Neoplasms;Hodgkin lymphoma
180;C0152276;4;DIS007681;4;86850;Myeloid sarcoma;Granulocytic Sarcoma;Neoplasms;Myeloid sarcoma
223;C0268226;8;DIS003369;46;309294;Sialidosis;Type I Mucolipidosis;Endocrine, nutritional and metabolic diseases;Sialidosis
224;C0268226;8;DIS003369;46;812;Sialidosis type 1;Type I Mucolipidosis;Endocrine, nutritional and metabolic diseases;Sialidosis
225;C0268226;8;DIS003811;15;309294;Sialidosis;Type I Mucolipidosis;Endocrine, nutritional and metabolic diseases;Mucolipidosis type IV
226;C0268226;8;DIS003811;15;812;Sialidosis type 1;Type I Mucolipidosis;Endocrine, nutritional and metabolic diseases;Mucolipidosis type IV
227;C0268226;8;DIS004849;9;309294;Sialidosis;Type I Mucolipidosis;Endocrine, nutritional and metabolic diseases;Pseudo-Hurler polydystrophy
228;C0268226;8;DIS004849;9;812;Sialidosis type 1;Type I Mucolipidosis;Endocrine, nutritional and metabolic diseases;Pseudo-Hurler polydystrophy
229;C0268226;8;DIS005506;33;309294;Sialidosis;Type I Mucolipidosis;Endocrine, nutritional and metabolic diseases;I-cell disease
230;C0268226;8;DIS005506;33;812;Sialidosis type 1;Type I Mucolipidosis;Endocrine, nutritional and metabolic diseases;I-cell disease
231;C0268226;8;DIS007879;3;309294;Sialidosis;Type I Mucolipidosis;Endocrine, nutritional and metabolic diseases;Mucolipidosis
232;C0268226;8;DIS007879;3;812;Sialidosis type 1;Type I Mucolipidosis;Endocrine, nutritional and metabolic diseases;Mucolipidosis
285;C0475801;3;DIS003790;7;86852;B-cell prolymphocytic leukemia;Leukemia, Prolymphocytic, B-Cell;Neoplasms;B-cell prolymphocytic leukemia
342;C1334968;13;DIS003466;87;86893;Nodular lymphocyte predominant Hodgkin lymphoma;Nodular Lymphocyte Predominant Hodgkin Lymphoma;Neoplasms;Hodgkin's lymphoma
343;C1334968;13;DIS013438;111;86893;Nodular lymphocyte predominant Hodgkin lymphoma;Nodular Lymphocyte Predominant Hodgkin Lymphoma;Neoplasms;Hodgkin lymphoma